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Abstract
Background: General practitioners (GPs) are in best position to suspect dementia. Mini-Mental State
Examination (MMSE) and Clock Drawing Test (CDT) are widely used. Additional neurological tests may increase
the accuracy of diagnosis. We aimed to evaluate diagnostic ability to detect dementia with a Short Smell Test
(SST) and Palmo-Mental Reflex (PMR) in patients whose MMSE and CDT are normal, but who show signs of
cognitive dysfunction.
Methods: This was a 3.5-year cross-sectional observational study in the Memory Clinic of the University
Department of Geriatrics in Bern, Switzerland. Participating patients with normal MMSE (>26 points) and CDT
(>5 points) were referred by GPs because they suspected dementia. All were examined according to a
standardized protocol. Diagnosis of dementia was based on DSM-IV TR criteria. We used SST and PMR to
determine if they accurately detected dementia.
Results: In our cohort, 154 patients suspected of dementia had normal MMSE and CDT test results. Of these,
17 (11 %) were demented. If SST or PMR were abnormal, sensitivity was 71 % (95 % CI 44–90 %), and
specificity 64 % (95 % CI 55–72 %) for detecting dementia. If both tests were abnormal, sensitivity was 24 %
(95 % CI 7–50 %), but specificity increased to 93 % (95 % CI 88–97 %).
Conclusion: Patients suspected of dementia, but with normal MMSE and CDT results, may benefit if SST and
PMR are added as diagnostic tools. If both SST and PMR are abnormal, this is a red flag to investigate these
patients further, even though their negative neuropsychological screening results.
Keywords: Dementia, Additional testing for dementia in cases of negative neuropsychological screening,
Short Smell Test (SST), Palmo-Mental Reflex (PMR)
Background
General practitioners (GPs) are in a good position to de-
tect dementia early. Cognitive dysfunction may be re-
ported by patients, caregivers, or relatives, or discovered
during general screening (e.g. while testing fitness to
drive). Early detection of dementia can reduce the burden
on the caregiver through effective intervention [1], and
can delay admission to a nursing home [2], and mitigate
the behavioural and psychological symptoms of dementia.
At this early stage, patients can also state preferences for
care, which may lower the rate of unwanted hospitalisa-
tion [3].
GPs often use the Mini-Mental State Examination
(MMSE) and the Clock Drawing Test (CDT) to test for de-
mentia. The CDT is popular because it assesses multiple
domains, particularly executive functions, based on a single
task. In Switzerland, the National Association of Swiss
Memory Clinics (SMC) [http://www.swissmemoryclinics.ch
last access July 15th, 2015] endorses using MMSE and
CDT [4]. Screening indications are self-reported cognitive
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dysfunction or suspicion for dementia by caregivers or rela-
tives, but it is challenging to detect dementia in its early
stages. Studies show that the rate at which these tests fail to
identify dementia patients is variable (MMSE 3 %–26 %, de-
pending on the cut-off [5, 6]; CDT alone 25 %) [7]. Com-
bining MMSE (cut off ≤24/30 points, which is very low)
and CDT returned a false negative rate of 9 % [8]. If GPs
can use easy and practical neurological tests to detect de-
mentia, they may be able to more accurately judge whether
a patient needs further investigation.
GPs refer patients suspected of dementia to Memory
Clinics, which were established to further examine pa-
tients whose screening test results were negative, but
who had abnormal cognitive test results or unexplained
cognitive dysfunction [4]. Memory Clinic staff conduct
in-depth interviews with patients and relatives or care-
givers and use additional neuropsychological tests to
diagnose dementia. Neither the Short Smell Test (SST)
nor the Palmo-Mental Reflex (PMR) test have been used
to detect dementia, but we chose SST and PMR because
they turn deficient early in various diffuse subcortical or
cortical encephalopathies that often lead to dementia:
Stamps et al. found that patients who could not detect
the odour of peanut butter with their left nostril were
likely to have Alzheimer’s disease [9]. In a review, Barresi
et al. found evidence that olfactory dysfunction is in-
volved in various neurological diseases [10]. PMR has
been described in detail in patients with dementia [11].
This primitive reflex is often present in diffuse diseases
like subcortical encephalopathies (with white matter
changes) [12] or more cortical encephalopathies (such as
Alzheimer’s Disease) [13].
Our study focused on patients whose results on the
MMSE and CDT were negative, but who were admitted
to a Swiss Memory Clinic because of suspected demen-
tia. We used a cross-sectional observational study to de-
termine if adding SST and PMR tests increased the
chances of dementia would be detected in patients whose
MMSE and CDT were normal.
Methods
Population
Our study was conducted in the Memory Clinic of the
University Department of Geriatrics in Bern, Switzerland,
one of over 37 Memory Clinics in Switzerland. According
to national quality standards, dementia is diagnosed in
every Swiss Memory Clinic by an expert team, based on
national and international guidelines. Every clinic sees at
least 100 outpatients each year. Because each Memory
Clinic records medical data differently, we located our
study in a single Memory Clinic that sees about 200 pa-
tients a year. Of these, about 60 % are diagnosed with
dementia.
Patients were referred by GPs who sought diagnos-
tic clarification, and who looked to the Memory
Clinic to detect and characterize underlying cognitive
disorders. Patients may have self-reported their con-
cerns about their mental state, relatives may have re-
ported concerns, or patients may have had abnormal
results on screening tests for dementia. We included
patients given MMSE and CDT tests in the Memory
Clinic, whose results on these tests were normal. Test
results were normal if MMSE was ≥27 out of 30
points (as suggested by Monsch et al. [6]) and CDT
≥6 out of 7 points (as suggested by Thalmann et al.
[14]; for detailed description see Table 2 in that art-
icle). We did not exclude any patients. We retrospect-
ively collected data from the medical records of all
consecutive patients admitted to this Memory Clinic
between May 2009 and December 2012. The Ethics
Committee of Bern approved the study. The National
Confederate Expert Panel for Professional Secrecy
permitted us to use personalized data.
General assessment
Residents in General Internal Medicine and Geriatrics
interviewed patients and clinically evaluated them
under the supervision of an attending physician. A
neuropsychologist supervised the neuropsychological
tests. Geriatricians in Switzerland are specialists in
general internal medicine, and have also completed a
3-year curriculum in geriatrics and psychiatry. Neuro-
psychologists have a Masters in psychology (MSc in
Psychology).
Patients were assessed in two sessions, based on a stan-
dardized protocol. In the first session, semi-structured in-
terviews were conducted with patients and, if possible, at
least one close relative or caregiver. Interviews covered
the following topics: personal data, education, reason for
admission, cognitive complaints, behavioural and psycho-
logical symptoms of dementia (BPSD), problems in prac-
tical daily routines, somatic problems, earlier medical
problems, family medical and social history. The inter-
viewer assessed basic and instrumental activities of daily
living (BADL, IADL) and applied the Nurses’ Observation
Scale for Geriatric Patients (NOSGER II). The clinical
examination checked for neurological abnormalities, and
also included the Short Smell Test (SST) and Palmo-
Mental Reflex (PMR), both of which are described in de-
tail in the next subsection. If the admitting GP had not
already ordered cerebral images and laboratory tests, the
Memory Clinic did these at the end of the first session. In
the second session, patients were given a standardised bat-
tery of neuropsychological tests, including the Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD
Plus) [15] and supplementary tests. (Additional file 1).
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Detailed description of short smell test (SST) and
Palmo-Mental Reflex (PMR)
Simple SST was considered abnormal if patients closed
their eyes and could not identify instant coffee powder
in a can when it was held 5–10 cm under their nose.
PMR was considered positive if brushing the thumb
under the thenar (the region of the palm at the base of the
thumb) elicited a unilateral chin muscle twitch. (See the
Youtube video we recorded to demonstrate the test [16]).
Standard diagnosis of dementia and its aetiology
After all the data is collected, dementia is diagnosed at the
Memory Clinic in two-steps. First, a team of experts (se-
nior consultant, neuropsychologist) diagnoses dementia
according to gold standard DSM-IV TR criteria [17]. The
team uses criteria set by the International Working Group
on Mild Cognitive Impairment to diagnose mild cognitive
impairment (MCI, defined as patients in cognitive decline,
who can still conduct basic and instrumental activities of
daily living, and do not meet DSM-IV TR criteria for de-
mentia) [18]. SST and PMR are not considered in this first
step, because dementia is not diagnosed based on defi-
ciencies revealed by SST and PMR. In the second step, the
team of experts assigns probable aetiology (e.g. for Alzhei-
mer’s disease, fronto-temporal dementia, dementia with
Lewy bodies, vascular dementia, mixed or other types of
dementia) based on published common consensus criteria
for the specific subtype of dementia. At this point, experts
may use SST and PMR results only to assist in determin-
ing the aetiology of dementia.
Assessing diagnostic accuracy of SST and PMR:
retrospective statistical analysis
Means and standard deviations or numbers and propor-
tions were used for descriptive statistics. We compared
categorical data with the chi-squared test and continu-
ous data with the t-test. To test inter-rater reliability,
two residents of the Memory Clinic independently ad-
ministered the PMR to a consecutive sample of patients
(n = 42) after the retrospective study.
To test diagnostic accuracy of SST and PMR, we cal-
culated the sensitivity, specificity and likelihood ratios
(LR), Receiver Operating Characteristic (ROC), and the
area under the ROC curve (AUC). In the first model, ei-
ther SST or PMR had to be abnormal to detect demen-
tia. In the second model, both SST and PMR had to be
abnormal to detect dementia. To adjust for the fact that
patients with dementia were significantly older, we strati-
fied them into two groups: younger and older patients.
We used STATA release 13.1 (Stata Corp, College
Station, TX, USA), and considered a p-value of 0.05 to
be statistically significant.
Results
Baseline characteristics
During the observation period of 3.5 years, our Memory
Clinic admitted 621 patients (Fig. 1). Of these, 62 % were
diagnosed with dementia. Residents worked at the Mem-
ory Clinic on a 3-month rotation, so the staff changed
over time. The senior physician and neuropsychologist
were the same throughout.
We included 154 patients in our study whose basic
examination fell within the normal range (MMSE ≥27
points and CDT ≥6 points). We detected 17 (11 %) cases
of dementia (Table 1). Patients with dementia were signifi-
cantly older than patients without dementia (p > 0.001);
there was no gender difference (p = 0.3; data not shown).
Types of dementia included Alzheimer’s disease (58 %),
mixed dementia (12 %), frontal dementia (12 %), vascular
dementia (6 %), or other type of dementia (12 %). No de-
mentia was found in 137 patients (89 %). There were no
objective findings for most of these patients with com-
plaints (53 %). Some had MCI (26 %), depression (15 %),
or another disease (6 %) (Table 1). SST was abnormal in
53 % of all patients with dementia, and abnormal in 25 %
of all patients without dementia (p = 0.015). PMR was ab-
normal in 41 % of all patients with dementia, and abnor-
mal in 18 % of all patients without dementia (p = 0.028).
There were also significant differences between patients
with and without dementia for MMSE and CDT, SST,
PMR); p-values were between 0.04–0.004.
Inter-rater reliability of PMR testing substantially agreed
(kappa 0.80, 95 % -CI 0.62 - 0.99, data not shown).
Diagnostic performance of SST and PMR
The first model shows that patients with at least one ab-
normal SST or PMR test were more likely to be demen-
ted (Fig. 2): Sensitivity was 71 % (95 % CI 44-90 %), and
specificity 64 % (95 % CI 55-72 %) for detecting demen-
tia. Among the 50 false positives, 19 patients (38 %) had
an MCI.
The second model shows that patients whose SST and
PMR are both abnormal are much more likely to have
dementia (Fig. 2). Specificity was very high (93 % [95 % CI
88-97 %]), but sensitivity was low (24 % [95 % CI 7-50 %]).
Of the 9 false positives, 5 patients (56 %) had MCI.
Since patients with dementia were significantly older
(Table 1), we stratified the second model into groups
aged >70 and <70 years (data not shown). Specificity in
patients aged <70 years was 96 % (95 % CI 88-99 %) and
90 % (95 % CI 80-96 %) in patients >70 years of age.
Discussion
SST and PMR were both helpful in detecting dementia
in patients with normal MMSE and CDT results. De-
mentia was present in over 93 % of patients whose SST
and PMR were both abnormal. A high percentage of
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patients with false positive results on the SST and PMR
(38 %-56 %) had MCI results that justified referral to a
specialized Memory Clinic.
As far as we can determine, this was the first study to
combine these two neurological tests with neuropsycho-
logical screening by the GP. Studies such as by Kato Y
et al. [8] described the combination of MMSE and CDT
as a powerful screening tool with high sensitivity and
specificity (89.4 vs. 83.9 %). Kato’s study is one of the
few studies to examine the tests in combination in a
sample of hospitalized patients. Devanand DP et al.
found that poor scores on smell tests predicted cognitive
decline in 1,037 patients in a community cohort in New
York, USA. This study suggests SST is an early bio-
marker of cognitive decline in patients with Alzheimer’s
disease [19]. Stanciu I et al. had similar results after fol-
lowing a Swedish cohort of 1,529 patients. Low scores
on odour identification tests independently predicted
conversion to dementia [20].
Limitations
Our sample size was small (154 patients), so the confi-
dence interval is wide, although we collected our samples
over a long observation period of 3.5 years. Although it is
plausible that loss of smell is related to dementia [21], ab-
normal SST can also be caused by other physiological
changes like decreased hydration and thinning of the ol-
factory mucosa [22]. Normal aging may account for the
increase in abnormal SST and PMR results, though our
sensitivity analysis showed that younger and older patients
had similar high specificity, regardless of gender. Infec-
tions or other pathologies may have impaired sense of
smell, even though patients and relatives were advised to
Fig. 1 Patient flow chart
Table 1 Baseline characteristics
Baseline characteristics Overall (n = 154)
Patient characteristics
Age, mean (SD) 68.5 (11)
Women, n (%) 81 (53)
Dementia, n (%) 17 (11)
Alzheimer’s disease 10 (58)
Mixed dementia 2 (12)
Frontal dementia 2 (12)
Vascular dementia 1 (6)
Other type of dementia 2 (12)
No dementia, no (%) 137 (89)
Complaints but no objective findings 72 (53)
Mild cognitive impairment (MCI) 36 (26)
Depression 21 (15)
Other disease 8 (6)
Test results
MMSEa, mean (SD) 28.5 (1.1)
CDTb, mean (SD) 7.0 (0.2)
Abnormal SSTc, n (%) 43 (28)
Positive PMRd, n (%) 32 (21)
Abnormal SST and positive PMR, n (%) 13 (8)
aMini-Mental state examination
bClock drawing test
cShort Smell Test
dPalmo-Mental Reflex
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shift their appointments if they had acute infections or
their general condition significantly deteriorated.
Some dismiss PMR because the methods used to elicit
results, and their interpretation are inconsistent [23].
We addressed this by standardizing PMR testing in our
study. We asked an experienced physician to teach new
colleagues how to administer the test. Thus, the prospect-
ive inter-rater reliability test showed substantial agree-
ment. Without good instructions PMR testing would be
difficult to successfully implement PMR testing in primary
care. We provide a teaching video that demonstrates the
way we performed the PMR test [16]. Though patients re-
ceive both SST and PMR tests as part of the standardized
protocol, and results are available to the expert team when
they diagnose dementia, the gold standard for diagnosing
dementia includes neither the SST nor the PMR.
Strengths
The standardized tests at our Memory Clinic gave us
very high quality data: none were missing. Our sample
of patients can be generalized to a broader population
because of its similar distribution of types of dementia
and other diagnoses beside dementia, such as depres-
sion. The relatively high cut-off we set for MMSE testing
(27 or more points judged as normal) reduced false
negative results, though using a lower cut-off would have
made SST and PMR even more sensitive.
Our findings indicate that both SST and PMR should
be validated in a primary care setting that ideally offers
other screening tests than MMSE and CDT as well. We
recommend that patients suspected of dementia, who
have abnormal SST and PMR, be evaluated further, even
if they have normal MMSE and CDT results. GPs should
see abnormal SST and PMR as a red flag that may indi-
cate dementia. If one or both tests are normal, we do
not suggest that a change in current practice is neces-
sary: patients, caregivers and doctors should together de-
cide the next steps to take. However, abnormal results
on both tests indicate that further testing is warranted.
Conclusions
For patients whose neuropsychological screening (MMSE,
CDT) is normal, but who are suspected of dementia, PMR
and SST offer additional diagnostic value. Because specifi-
city is very high (93 %), we suggest abnormal results on
both the PMR and SST are a red flag for GPs, indicating
patients should be further evaluated. Mild cognitive im-
pairment was common among individuals with false posi-
tive results for PMR and SST, so we recommend further
testing. Adding PMR and SST to dementia evaluations
may help physicians to detect dementia early, and reduce
its burden through early intervention.
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